Daviess County - Indiana Criminal Code 2022

328

CRIMINAL LAWAND PROCEDURE

mixture, or preparation containing any of the fol lowing narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in the fol lowing quantities, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the com pound, mixture, or preparation, valuable medic inal qualities other than those possessed by the narcotic drug alone: (1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams. (2) Not more than 100 milligrams of dihy drocodeine per 100 milliliters or per 100 grams. (3) Not more than 100 milligrams of eth ylmorphine per 100 milliliters or per 100 grams. (4) Not more than 2.5 milligrams of diphe noxylate and not less than 25 micrograms of atropine sulfate per dosage unit. (5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams. (6) Not more than 0.5 milligrams of difenoxin (9168), and not less than 25 micrograms of atropine sulfate per dosage unit. (c) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-prop ylpyrrolidin-1-yl] butanamide)). (d) Pregabalin (2782). (e) Pyrovalerone (1485). (f) Lacosamide [(R)-2-acetoamido-N-benzyl- 3-methoxy-propionamide]. (g) Zulresso (brexanolone) 3a-hydroxy 5apregnan-20-one. Other name: allopregnanolone. 35-48-2-14. Reclassification of controlled substances. (a) The board may adopt rules under IC 4-22 2 to reclassify a controlled substance: (1) From a more restrictive schedule to a less restrictive schedule; or (2) As a substance that is not a controlled substance; if the board finds that the substance qualifies for reclassification under this chapter and that the same reclassification has been made in a con trolled substance schedule under federal law. (b) If the board reclassifies a controlled sub-

Sibutramine (1675). SPA((-)-1-dimethylamino-1,2-diphenyl- ethane (1635). (f) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances including its salts: Butorphanol (including its optical isomers) (9720). Pentazocine (9709). (g) Tramadol (Ultram). (h) The board may except by rule any com pound, mixture, or preparation containing any depressant substance listed in subsection (b), (c), (d), (e), or (f) from the application of any part of this article if the compound, mixture, or prepara tion contains one (1) or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, pro portion, or concentration that vitiate the potential for abuse of the substances which have a depres sant effect on the central nervous system. 35-48-2-11. Schedule V tests. (a) The board shall recommend placement of a substance in schedule V under this chapter if it finds that: (1) The substance has a low potential for abuse relative to the controlled substances listed in schedule IV under this chapter; (2) The substance has currently accepted medical use in treatment in the United States; and (3) The substance has limited physical dependence or psychological dependence liability relative to the controlled sub stances listed in schedule IV under this chapter. (b) The board may recommend placement of a substance in schedule V under this chapter if it finds that the substance is classified as a con trolled substance in schedule V under federal law. 35-48-2-12. Schedule V. (a) The controlled substances listed in this section are included in schedule V. (b) Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound,